Market cap
₹199 Cr
Recently Viewed
Clear AllNSE: MKPL | BSE: 543919
₹5.31
₹-0.04
(-0.75%)
As on 30-Apr-2026IST
Market cap
₹199 Cr
Revenue (TTM)
₹374 Cr
P/E Ratio
23.5
P/B Ratio
2.7
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹8 Cr
ROE
12.9 %
ROCE
13.5 %
Industry P/E
22.51
EV/EBITDA
14.6
Debt to Equity
0.5
Book Value
₹2
EPS
₹0.2
Face value
1
Shares outstanding
375,372,000
CFO
₹-12.12 Cr
EBITDA
₹102.21 Cr
Net Profit
₹57.71 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
MK Proteins
| -12.5 | 19.6 | -5.3 | -19.7 | -40.6 | -- | -- |
|
BSE FMCG
| -6.3 | 12.6 | 0.8 | -7.9 | 3.1 | 8.4 | 9.4 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
MK Proteins
| -25.5 | -66.1 | 12.6 | 1,750.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE FMCG
| -2.1 | 1.5 | 27.3 | 16.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
MK Proteins
|
5.3 | 199.3 | 374.1 | 8.5 | 3.5 | 11.9 | 23.5 | 2.7 |
| 35.7 | 1,055.5 | 3,039.3 | 128.0 | 6.1 | 14.2 | 9 | 1.2 | |
| 1,629.8 | 4,561.0 | 2,068.1 | 169.1 | 14.7 | 8.5 | 27 | 2.2 | |
| 232.8 | 6,874.1 | 23,338.9 | 299.6 | 2.3 | 26.6 | 23 | 5.3 | |
| 39.7 | 390.6 | 3,924.8 | 19.3 | 0.8 | 5.5 | 20.3 | 1.1 | |
| 98.5 | 490.6 | 866.3 | 32.6 | 4.0 | 14.7 | 15.1 | 2.1 | |
| 13.6 | 450.5 | 3,384.5 | 45.2 | 1.7 | 14.9 | 10 | 1.8 | |
| 375.8 | 498.6 | 666.0 | 38.8 | 8.6 | 29.4 | 12.9 | 3.3 | |
| 49.5 | 239.8 | 83.1 | -4.8 | -3.6 | -2 | -- | 1.1 | |
| 11.8 | 302.9 | 236.4 | -1.0 | 0.3 | -1.3 | -- | 9.9 |
No Review & Analysis are available.
M. K. Proteins Limited engages in the manufactures and trades in vegetable refined oil and by-products in India. It offers rice bran, sunflower, cotton seed, soya bean, palm, canola, and rice bran bleached oils. The company also provides by-products,... including rice bran fatty acid oils, rice bran waxes, gums, and spent earth; imports, processes, and sells crude oils; and trades in edible and non-edible oils. M. K. Proteins Limited was incorporated in 2012 and is based in Ambala, India. Read more
Incorporated
2012
Chairman
Parvind Kumar
Managing Director
Parmod Kumar
Headquarters
Ambala, Haryana
Website
Looking for more details about MK Proteins Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of MK Proteins Ltd is ₹5.31 (NSE) and ₹5.31 (BSE) as of 30-Apr-2026 IST. MK Proteins Ltd has given a return of -40.6% in the last 3 years.
The P/E ratio of MK Proteins Ltd is 23.48 times as on 30-Apr-2026, a 4 premium to its peers’ median range of 22.51 times.
The P/B ratio of MK Proteins Ltd is 2.65 times as on 30-Apr-2026, a 42 premium to its peers’ median range of 1.86 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
27.00
|
3.26
|
|
2024
|
33.08
|
6.07
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.09
|
2.02
|
|
2021
|
0.04
|
1.13
|
The 52-week high and low of MK Proteins Ltd are Rs 9.78 and Rs 3.56 as of 30-Apr-2026.
MK Proteins Ltd has a market capitalisation of ₹ 199 Cr as on 30-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in MK Proteins Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.